• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS MEDICAL SYSTEMS CORP. THUNDERBEAT 5 MM, 35 CM, FRONT-ACTUATED GRIP TYPE S; ULTRASONIC SURGICAL DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS MEDICAL SYSTEMS CORP. THUNDERBEAT 5 MM, 35 CM, FRONT-ACTUATED GRIP TYPE S; ULTRASONIC SURGICAL DEVICE Back to Search Results
Model Number TB-0535FCS
Device Problem Mechanical Problem (1384)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Urinary Tract Infection (2120); Vascular Dissection (3160)
Event Date 11/01/2021
Event Type  Injury  
Event Description
Hold gn 12-15 the following literature article was identified by olympus: a pilot randomized controlled trial comparing thunderbeat to the maryland ligasure energy device in laparoscopic left colon surgery by jeffrey w.Milsom1 · koianka trencheva1 · kota momose1 · miroslav p.Peev1 · paul christos2 · parul j.Shukla1 · kelly garrett1.Source: doi: 10.1007/s00464-021-08765-8.Abstract: background: the thunderbeat is a multi-functional energy device which delivers both ultrasonic and bipolar energy, but there are no randomized trials which can provide more rigorous evaluation of the clinical performance of thunderbeat compared to other energy-based devices in colorectal surgery.The aim of this study was to compare the clinical performance of thunderbeat energy device to maryland ligasure in patients undergoing left laparoscopic colectomy.Methods: prospective randomized trial with two groups: group 1 thunderbeat and group 2 ligasure in a single university hospital.60 subjects, male and female, of age 18 years and above undergoing left colectomy for cancer or diverticulitis were included.The primary outcome was dissection time to specimen removal (dtsr) measured in minutes from the start of colon mobilization to specimen removal from the abdominal cavity.Versatility (composite of five variables) was measured by a score system from 1 to 5 (1 being worst and 5 the best), and adjusted/weighted by coefficient of importance with distribution of the importance as follow: hemostasis 0.275, sealing 0.275, cutting 0.2, dissection 0.15, and tissue manipulation 0.1.Other variables were: dryness of surgical field, intraoperative and postoperative complications, and mortality.Follow-up time was 30 days.Results: 60 patients completed surgery, 31 in group 1 and 29 in group 2.There was no difference in the dtsr between the groups, 91 min vs.77 min (p = 0.214).Thunderbeat showed significantly higher score in dissecting and tissue manipulation in segment 3 (omental dissection), and in overall versatility score (p = 0.007) as well as versatility score in segment 2 (retroperitoneal dissection p = 0.040) and segment 3 (p = 0.040).No other differences were noted between the groups.Conclusions: both energy devices can be employed effectively and safely in dividing soft tissue and sealing mesenteric blood vessels during laparoscopic left colon surgery, with thunderbeat demonstrating some advantages over ligasure during omental dissection and tissue manipulation.Study design: patients undergoing laparoscopic left colectomy for their medical condition were randomized with equal chances into one of two groups: group 1¿thunderbeat and group 2¿ligasure.Population: sixty patients, male and female, age 18 years and above and american society of anesthesiologists (asa) class between 1 and 3, undergoing elective left laparoscopic colectomy for neoplasm or diverticulitis.Study instruments: thunderbeat 5 mm to 35 cm (olympus, japan).The tb device has been cleared under 510 (k) by fda and currently used for regular care.The surgeons were able to coagulate blood vessels up to 7 mm, cut and dissect during surgery.The device consists of: thunderbeat device and generator.The device is provided sterile and intended for single use only.The generators settings were the same for all cases in this study.All participating surgeons were trained in using tb and maryland ligasure devices as they are used daily for regular surgical care, and surgeons used the devices on at least 10 patients prior to this study.Equipment results: seventy three patients were enrolled in the study from february 2016 to april 2019, and sixty of them were randomized into the two groups: n=31 in group 1: thunderbeat and n=29 in group 2: ligasure and included in the analyses.Preoperative diagnosis in thunderbeat group (n=31): neoplasm, diverticulitis; preoperative comorbidities: hypertension, coronary artery disease, diabetes, others/unspecified; 1 patient converted to open surgery.Adverse events in thunderbeat group: intraoperative complications: sealing unsuccessful = 2.Bleeding at time of sealing= 3.Bleeding mesentery dissection= 4.Estimated blood loss 87mls±97 mls.Postoperative ileus =1.Wound hematoma incision = 1.Uti= 1.Reoperation= 2.Readmission= 1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THUNDERBEAT 5 MM, 35 CM, FRONT-ACTUATED GRIP TYPE S
Type of Device
ULTRASONIC SURGICAL DEVICE
Manufacturer (Section D)
OLYMPUS MEDICAL SYSTEMS CORP.
2951 ishikawa-cho
hachioji-shi, tokyo-to 192-8 507
JA  192-8507
MDR Report Key12977166
MDR Text Key282266614
Report Number2951238-2021-00448
Device Sequence Number1
Product Code GEI
UDI-Device Identifier04953170383540
UDI-Public04953170383540
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 11/11/2021,12/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTB-0535FCS
Device Lot NumberUNKNOWN (LITERATURE)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date11/11/2021
Event Location Hospital
Date Report to Manufacturer11/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
-
-